172 related articles for article (PubMed ID: 20515065)
1. Tautomer preference in PDB complexes and its impact on structure-based drug discovery.
Milletti F; Vulpetti A
J Chem Inf Model; 2010 Jun; 50(6):1062-74. PubMed ID: 20515065
[TBL] [Abstract][Full Text] [Related]
2. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
[TBL] [Abstract][Full Text] [Related]
3. Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes.
Sándor M; Kiss R; Keseru GM
J Chem Inf Model; 2010 Jun; 50(6):1165-72. PubMed ID: 20459088
[TBL] [Abstract][Full Text] [Related]
4. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.
Stroganov OV; Novikov FN; Stroylov VS; Kulkov V; Chilov GG
J Chem Inf Model; 2008 Dec; 48(12):2371-85. PubMed ID: 19007114
[TBL] [Abstract][Full Text] [Related]
5. The impact of tautomer forms on pharmacophore-based virtual screening.
Oellien F; Cramer J; Beyer C; Ihlenfeldt WD; Selzer PM
J Chem Inf Model; 2006; 46(6):2342-54. PubMed ID: 17125178
[TBL] [Abstract][Full Text] [Related]
6. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
[TBL] [Abstract][Full Text] [Related]
7. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
8. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design.
Lu Y; Wang Y; Zhu W
Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531
[TBL] [Abstract][Full Text] [Related]
9. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
Kellenberger E; Foata N; Rognan D
J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
[TBL] [Abstract][Full Text] [Related]
10. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
11. Tautomer enumeration and stability prediction for virtual screening on large chemical databases.
Milletti F; Storchi L; Sforna G; Cross S; Cruciani G
J Chem Inf Model; 2009 Jan; 49(1):68-75. PubMed ID: 19123923
[TBL] [Abstract][Full Text] [Related]
12. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.
Sastry GM; Adzhigirey M; Day T; Annabhimoju R; Sherman W
J Comput Aided Mol Des; 2013 Mar; 27(3):221-34. PubMed ID: 23579614
[TBL] [Abstract][Full Text] [Related]
13. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
Virtanen SI; Pentikäinen OT
J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
[TBL] [Abstract][Full Text] [Related]
14. FLAP: GRID molecular interaction fields in virtual screening. validation using the DUD data set.
Cross S; Baroni M; Carosati E; Benedetti P; Clementi S
J Chem Inf Model; 2010 Aug; 50(8):1442-50. PubMed ID: 20690627
[TBL] [Abstract][Full Text] [Related]
15. The low energy tautomers and conformers of the dipeptides HisGly and GlyHis and of their sodium ion complexes in the gas phase.
Kapota C; Ohanessian G
Phys Chem Chem Phys; 2005 Nov; 7(21):3744-55. PubMed ID: 16358024
[TBL] [Abstract][Full Text] [Related]
16. N-H...O, O-H...O, and C-H...O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition.
Sarkhel S; Desiraju GR
Proteins; 2004 Feb; 54(2):247-59. PubMed ID: 14696187
[TBL] [Abstract][Full Text] [Related]
17. Minimizing false positives in kinase virtual screens.
Perola E
Proteins; 2006 Aug; 64(2):422-35. PubMed ID: 16708364
[TBL] [Abstract][Full Text] [Related]
18. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
19. SuperStar: improved knowledge-based interaction fields for protein binding sites.
Verdonk ML; Cole JC; Watson P; Gillet V; Willett P
J Mol Biol; 2001 Mar; 307(3):841-59. PubMed ID: 11273705
[TBL] [Abstract][Full Text] [Related]
20. Accuracy assessment of protein-based docking programs against RNA targets.
Li Y; Shen J; Sun X; Li W; Liu G; Tang Y
J Chem Inf Model; 2010 Jun; 50(6):1134-46. PubMed ID: 20481574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
